XML 24 R37.htm IDEA: XBRL DOCUMENT v2.4.0.8
GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Changes in Carrying Amount of Goodwill (Details) (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2014
Dec. 31, 2013
Goodwill [Line Items]    
Goodwill, gross   $ 296,502
Accumulated impairment losses   (46,738)
Goodwill [Roll Forward]    
Goodwill at December 31, 2013 249,764 [1]  
Goodwill acquired during period 105,331  
Foreign currency translation (5,521)  
Goodwill at September 30, 2014 349,574  
U.S. Neurosurgery
   
Goodwill [Line Items]    
Goodwill, gross   95,165
Accumulated impairment losses   0
Goodwill [Roll Forward]    
Goodwill at December 31, 2013 95,165  
Goodwill acquired during period 95,373  
Foreign currency translation (2,966)  
Goodwill at September 30, 2014 187,572  
U.S. Instruments
   
Goodwill [Line Items]    
Goodwill, gross   58,033
Accumulated impairment losses   0
Goodwill [Roll Forward]    
Goodwill at December 31, 2013 58,033  
Goodwill acquired during period 0  
Foreign currency translation (901)  
Goodwill at September 30, 2014 57,132  
U.S. Extremities
   
Goodwill [Line Items]    
Goodwill, gross   61,079
Accumulated impairment losses   0
Goodwill [Roll Forward]    
Goodwill at December 31, 2013 61,079  
Goodwill acquired during period 0  
Foreign currency translation (948)  
Goodwill at September 30, 2014 60,131  
U.S. Spine And Other [Member]
   
Goodwill [Line Items]    
Goodwill, gross   56,325
Accumulated impairment losses   (46,738)
Goodwill [Roll Forward]    
Goodwill at December 31, 2013 9,587  
Goodwill acquired during period 0  
Foreign currency translation (149)  
Goodwill at September 30, 2014 9,438  
International
   
Goodwill [Line Items]    
Goodwill, gross   25,900
Accumulated impairment losses   0
Goodwill [Roll Forward]    
Goodwill at December 31, 2013 25,900  
Goodwill acquired during period 9,958  
Foreign currency translation (557)  
Goodwill at September 30, 2014 $ 35,301  
[1] See Note 1 of these condensed consolidated financial statements for discussion of the impact of the change in accounting for the medical device excise tax.